Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Upsizes Its Bought Deal Offering Due to Surge in Demand
Cybin's latest offering generated exceptional demand; announces upsize of "bought deal" offeringBurgeoning psychedelic sector attracts investors’ attention as compound may prove effective in mental health treatments.Cybin appears set for rapid growth as research accelerates, public acceptance grows. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotech company focused on psychedelic therapeutics for various psychiatric and neurological conditions, has announced that it has upsized the terms of its…